N-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide derivatives, processes for their preparation and pharmaceutical compositions comprising them

摘要

Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.